PAN: Non-Hodgkin's Lymphoma (Medicare): Waitlist
Patient Access Network (PAN) Foundation
The PAN: Non-Hodgkin's Lymphoma (Medicare): Waitlist program offers financial assistance for medication costs to eligible US and Puerto Rico residents with Medicare coverage for Non-Hodgkin's Lymphoma. It provides an annual maximum benefit of $3600 and is needs-based, requiring patients to meet specific income criteria to qualify for funding for drugs like Rituxan, Revlimid, and Imbruvica.
- Covers
- financial assistance
- Max award
- $3,600
- Enrollment cycle
- as_funded
Eligibility
Patients must have Medicare coverage, reside in the U.S. or Puerto Rico, and have a qualifying diagnosis of Non-Hodgkin's Lymphoma. This needs-based program provides up to $3,600 in annual financial assistance to help cover the costs of specific medications.
Apply
Application goes directly to Patient Access Network (PAN) Foundation. RxCopays does not receive compensation.
Go to application →Status source
PAN: Non-Hodgkin's Lymphoma (Medicare): Waitlist
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: